Skip to main content
Quadient logo

Quadient

Security and trust center evidence

quadient.comBusiness servicesLast verified 17 Sep 2026

Summary

Quadient has 3 registry-verified rows in the CertReports index, last verified 17 Sep 2026. The strongest row is FedRAMP: FedRAMP Authorized. This page is independent of the vendor’s own trust centre: dates, sources and caveats come from CertReports captures.

Reviewer brief

As of 17 Sep 2026, Quadient is listed in the FedRAMP registry as FedRAMP Authorized, with the authorization issued 14 Mar 2025 and audited by A-LIGN Compliance and Security, Inc. dba A-LIGN. As of 17 Sep 2026, Quadient is listed in the CSA STAR registry at Level 1 self-assessment (CAIQ), issued 24 Oct 2019. As of 17 Sep 2026, Quadient is listed in the EU-US Data Privacy Framework registry as Active across EU-US, SW-US, and UK Extension Certifications, issued 16 Jun 2025 and expiring 23 Jun 2027. As of 17 Sep 2026, no public evidence found for SOC 2 or HIPAA frameworks for Quadient. As of 17 Sep 2026, no subprocessor evidence rows were provided for Quadient.

  • FedRAMP: listed in FedRAMP registry as FedRAMP Authorized, issued 14 Mar 2025, audited by A-LIGN (as of 17 Sep 2026)
  • CSA STAR: listed in CSA STAR registry at Level 1 self-assessment (CAIQ), issued 24 Oct 2019 (as of 17 Sep 2026)
  • EU-US Data Privacy Framework: listed in DPF registry as Active (EU-US, SW-US, UK Extension), issued 16 Jun 2025, expires 23 Jun 2027 (as of 17 Sep 2026)

Facts only, each dated; nothing here is inferred, scored or advised. Brief generated 17 Sep 2026; it is regenerated whenever a row changes.

Among business services vendors

3verified rows

Category median 0.5, across 82 indexed business services vendors. Quadient has more verified rows than 100 percent of them.

communication managementcustomer engagementcustomer experiencedocument automation

Compliance grid

Subprocessors

No subprocessor list captured yet.

Similar vendors with evidence

Related by product tags and the Business services category, ranked by shared tags, description similarity and overlapping evidence. Never by popularity.